Craig Collard - 13 Sep 2021 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Director
Signature
/s/ Craig Collard
Issuer symbol
OPNT
Transactions as of
13 Sep 2021
Net transactions value
+$67,062
Form type
4
Filing time
15 Sep 2021, 16:01:35 UTC
Previous filing
13 Sep 2021
Next filing
24 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Purchase $45,325 +2,500 +18% $18.13 16,077 13 Sep 2021 Direct F1
transaction OPNT Common Stock Award $9,088 +506 +3.1% $17.96 16,583 13 Sep 2021 Direct F2
transaction OPNT Common Stock Award $12,649 +700 +4.2% $18.07 17,283 13 Sep 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $18.05 to $18.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $17.94 to $17.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $18.02 to $18.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.